Health
Researchers from CU ¶¶Òõ´«Ã½ÔÚÏß have found that the pandemic reshaped how people age 55 and older interact with their communities while highlighting the importance of "social infrastructure."
A CU ¶¶Òõ´«Ã½ÔÚÏß lab is exploring how age-related hearing loss rewires the brain—and whether hearing aids can undo the damage.
Supported by an up to $25 million federal award, a dream team of experts is working to develop the world’s first off-the-shelf engineered liver tissue.
Humans tend to move faster when they think they're going to get a reward. A new experiment explores the pathways in the brain that may be behind these patterns.
Doctoral student William Frantz is developing microscopic droplets designed to help doctors track radiation therapy in real time. His pitch at the Lab Venture Challenge highlighted how the technology could make cancer treatment more precise and less harmful, particularly for pediatric patients.
The CU ¶¶Òõ´«Ã½ÔÚÏß biochemist has been awarded for her career dedication to the study of nucleosomes and groundbreaking discoveries.
Toxic protein clusters known as tau aggregates underlie dozens of neurodegenerative diseases, or "tauopathies." New research illuminates why they form and spread and how to stop them.
Sanna Darvish discusses the interventions her research has identified to improve heart health and the steps the Integrative Physiology of Aging Laboratory has taken to address accessibility challenges for people in underrepresented groups.
New research shows that a little-known brain pathway plays a critical role in making pain last after tissue heals. The findings could help pave the way for new brain-machine interfaces and medications that ease suffering without the use of opioids.
CU ¶¶Òõ´«Ã½ÔÚÏß and two other CU campuses have been chosen from a nationwide search to partner with Medtronic—a global leader in health care technology—in a strategic research agreement aimed at accelerating transformative health innovations.